+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Abdominal hydatid disease: follow-up of mebendazole therapy by CT and ultrasonography



Abdominal hydatid disease: follow-up of mebendazole therapy by CT and ultrasonography



International Surgery 71(1): 22-26



Computed tomography (CT) and Ultrasonography (US) were used for the diagnosis and follow-up of 10 cases of abdominal hydatid disease receiving treatment with Mebendazole because of a relative contraindication to surgery. With the exception of one case, the duration of follow-up varied from 20-36 months. There was an estimated 60% decrease in cyst size in one case, 10% decrease in another, unchanged in six (mostly calcified ones) and 60% increase in one case. CT density measurements of fluid content of the cysts increased in three cases accompanied by increased internal echoes on US in one case. The number and size of daughter cysts were reduced in one case and more calcification was noted in two cases. There was an overall slow and poor response to treatment and four cases eventually had surgery.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039142942

Download citation: RISBibTeXText

PMID: 3522467


Related references

Medical therapy with mebendazole in hydatid cyst disease. A follow-up of 40 cases. Minerva Medica 80(3): 205-214, 1989

Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. European Journal of Clinical Pharmacology 31(4): 443-448, 1986

Experimental treatment of alveolar hydatid disease x. the effect of mebendazole bcg or mebendazole levamisole combinations on the course of hydatid disease simulated in mice. Meditsinskaya Parazitologiya i Parazitarnye Bolezni (6): 27-31, 1986

Chemotherapy of human hydatid disease with mebendazole. Follow-up of 16 cases. Acta Gastro-Enterologica Belgica 43(1-3): 48-65, 1980

Mebendazole therapy in extensive hydatid disease. Indian Journal of Gastroenterology 11(1): 40, 1992

Leukopenia associated with mebendazole therapy of hydatid disease. American Journal of Tropical Medicine and Hygiene 29(6): 1356-1358, 1980

Agranulocytosis, a complication of mebendazole therapy for hydatid disease. Meditsinskaya Parazitologiya i Parazitarnye Bolezni ( 5-6): 9-11, 1992

Efficacy of mebendazole therapy of patients with hydatid disease. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 0(4): 15-17, 1993

Therapy of human hydatid disease with mebendazole and albendazole. Antimicrobial Agents and ChemoTherapy 37(8): 1679-1684, 1993

Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. American Journal of Tropical Medicine and Hygiene 33(1): 132-137, 1984

Alopecia areata universalis following high dose mebendazole therapy for hydatid disease. Iranian Journal of Medical Sciences 21(3-4): 173-175, 1996

Echinococcus granulosus experimental hydatid disease of balb c mice therapy with mebendazole and thiabendazole. Rivista di Parassitologia 39(2-3): 199-204, 1978

Consequences of continuous mebendazole therapy in alveolar hydatid disease--with a summary of a ten-year clinical trial. Annals of Tropical Medicine and Parasitology 80(4): 403-419, 1986

Therapy of human hydatid disease with mebendazole: first attempts of correlating plasma and cyst levels with therapeutic results. Giornale di Malattie Infettive e Parassitarie 37(1/3): 88-90, 1985

Mebendazole in the treatment of the acute and chronic stages of helminthiases. II. Mebendazole (Vermox) in the treatment of alveolar hydatid disease and echinococcosis. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 48(5): 17-24, 1979